Covenant Asset Management, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Covenant Asset Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2023 Jul 12, 2023	BUY	$700.03 - $830.35 $2.45 Million - $2.91 Million	3,500 New	3,500 $2.51 Million
Q4 2022 Jan 24, 2023	BUY	$705.89 - $766.39 $9.67 Million - $10.5 Million	13,700 New	13,700 $0

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $110B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.